SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Karlsson Anders Professor)
 

Search: WFRF:(Karlsson Anders Professor) > (2020-2024) > The grade of indivi...

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

Nilsson, Erik (author)
Umeå universitet,Radiofysik
Sandgren, Kristina (author)
Umeå universitet,Radiofysik
Grefve, Josefine (author)
Umeå universitet,Radiofysik
show more...
Jonsson, Joakim, 1984- (author)
Umeå universitet,Radiofysik
Axelsson, Jan, 1966- (author)
Umeå universitet,Radiofysik
Keeratijarut Lindberg, Angsana (author)
Umeå universitet,Radiofysik
Söderkvist, Karin (author)
Umeå universitet,Onkologi
Thellenberg Karlsson, Camilla, 1972- (author)
Umeå universitet,Onkologi
Widmark, Anders (author)
Umeå universitet,Onkologi
Blomqvist, Lennart (author)
Karolinska Institutet,Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden
Strandberg, Sara, 1976- (author)
Umeå universitet,Diagnostisk radiologi
Riklund, Katrine, MD, PhD, Professor, 1963- (author)
Umeå universitet,Diagnostisk radiologi
Bergh, Anders (author)
Umeå universitet,Patologi
Nyholm, Tufve (author)
Umeå universitet,Radiofysik
show less...
 (creator_code:org_t)
Springer Nature, 2023
2023
English.
In: Communications Medicine. - : Springer Nature. - 2730-664X. ; 3:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) are widely used for the management of prostate cancer (PCa). However, how these modalities complement each other in PCa risk stratification is still largely unknown. We aim to provide insights into the potential of mpMRI and PET for PCa risk stratification.Methods: We analyzed data from 55 consecutive patients with elevated prostate-specific antigen and biopsy-proven PCa enrolled in a prospective study between December 2016 and December 2019. [68Ga]PSMA-11 PET (PSMA-PET), [11C]Acetate PET (Acetate-PET) and mpMRI were co-registered with whole-mount histopathology. Lower- and higher-grade lesions were defined by International Society of Urological Pathology (ISUP) grade groups (IGG). We used PET and mpMRI data to differentiate between grades in two cases: IGG 3 vs. IGG 2 (case 1) and IGG ≥ 3 vs. IGG ≤ 2 (case 2). The performance was evaluated by receiver operating characteristic (ROC) analysis.Results: We find that the maximum standardized uptake value (SUVmax) for PSMA-PET achieves the highest area under the ROC curve (AUC), with AUCs of 0.72 (case 1) and 0.79 (case 2). Combining the volume transfer constant, apparent diffusion coefficient and T2-weighted images (each normalized to non-malignant prostatic tissue) results in AUCs of 0.70 (case 1) and 0.70 (case 2). Adding PSMA-SUVmax increases the AUCs by 0.09 (p < 0.01) and 0.12 (p < 0.01), respectively.Conclusions: By co-registering whole-mount histopathology and in-vivo imaging we show that mpMRI and PET can distinguish between lower- and higher-grade prostate cancer, using partially discriminative cut-off values.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view